{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:30:43Z","timestamp":1788582643856,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS","award":["DIPLOMAT - PNRR-MR1-2022-12375735"],"award-info":[{"award-number":["DIPLOMAT - PNRR-MR1-2022-12375735"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Fabry disease (FD) is a rare lysosomal storage disorder caused by mutations in the GLA gene, resulting in globotriaosylceramide accumulation. Kidney involvement (Fabry nephropathy) significantly contributes to morbidity and mortality. Diagnosis can be difficult, especially in females or late-onset variants. Renal biopsy remains essential, but interpretation requires expert pathologists. Digital pathology and artificial intelligence (AI) offer promising solutions to support diagnosis. The study analyzed Whole-slide images from renal biopsies of Fabry nephropathy patients to develop and validate a \u201cfoamy podocytes\u201d screening AI tool. Two computational tasks were performed: glomerular-level classification, and podocyte-level segmentation. Performance was evaluated using standard metrics. A novel ZEBRA score (fpA\/tgA%) was developed to quantify disease burden, and correlations with histological scores and clinical parameters were assessed. EfficientNetB2 achieved the highest classification accuracy (79%) in identifying foamy podocytes. SegFormerB4 had the best segmentation performance (Dice\u2009=\u20090.46, IoU\u2009=\u20090.37). The ZEBRA score effectively distinguished Fabry nephropathy from controls (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and showed good correlation with manual scoring (rs\u2009=\u20090.66\u20130.71). The AI-assisted ZEBRA pipeline highlights high-risk Fabry nephropathy features to support nephropathologists as a screening tool.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-35466-w","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:54:40Z","timestamp":1768208080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathy"],"prefix":"10.1038","volume":"16","author":[{"given":"Giorgio","family":"Cazzaniga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Barretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Casati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Vatrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisella","family":"Vischini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Mignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianandrea","family":"Pasquinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pieruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Caroti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egrina","family":"Dervishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Allinovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albino","family":"Eccher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"L\u2019Imperio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"35466_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain, D. P. Fabry disease. Orphanet J. Rare Dis. 5, 30 (2010).","journal-title":"Orphanet J. Rare Dis."},{"key":"35466_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10157-021-02058-z","volume":"25","author":"S Feriozzi","year":"2021","unstructured":"Feriozzi, S. & Rozenfeld, P. Pathology and pathogenic pathways in Fabry nephropathy. Clin. Exp. Nephrol. 25, 925\u2013934 (2021).","journal-title":"Clin. Exp. Nephrol."},{"key":"35466_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/cge.12386","volume":"86","author":"A Pisani","year":"2014","unstructured":"Pisani, A. et al. The kidney in fabry\u2019s disease. Clin. Genet. 86, 301\u2013309 (2014).","journal-title":"Clin. Genet."},{"key":"35466_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton, M. H. et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine 81, 122\u2013138 (2002).","journal-title":"Medicine"},{"key":"35466_CR5","doi-asserted-by":"publisher","first-page":"107558","DOI":"10.18632\/oncotarget.22505","volume":"8","author":"F Scionti","year":"2017","unstructured":"Scionti, F. et al. Genetic variants associated with Fabry disease progression despite enzyme replacement therapy. Oncotarget 8, 107558\u2013107564 (2017).","journal-title":"Oncotarget"},{"key":"35466_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000502907","volume":"143","author":"E Riccio","year":"2019","unstructured":"Riccio, E., Sabbatini, M., Capuano, I. & Pisani, A. Early biomarkers of Fabry nephropathy: A review of the literature. Nephron 143, 274\u2013281 (2019).","journal-title":"Nephron"},{"key":"35466_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000369309","volume":"129","author":"C T\u00f8ndel","year":"2015","unstructured":"T\u00f8ndel, C. et al. Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria. Nephron 129, 16\u201321 (2015).","journal-title":"Nephron"},{"key":"35466_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00467-023-06050-5","volume":"39","author":"J Avarappattu","year":"2024","unstructured":"Avarappattu, J., Gaspert, A., Spart\u00e0, G. & Rohrbach, M. Impact of kidney biopsy on deciding when to initiate enzyme replacement therapy in children with Fabry disease. Pediatr. Nephrol. 39, 131\u2013140 (2024).","journal-title":"Pediatr. Nephrol."},{"key":"35466_CR9","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1093\/ndt\/gfp528","volume":"25","author":"AB Fogo","year":"2010","unstructured":"Fogo, A. B. et al. Scoring system for renal pathology in Fabry disease: report of the international study group of Fabry nephropathy (ISGFN). Nephrol. Dial Transpl. 25, 2168\u20132177 (2010).","journal-title":"Nephrol. Dial Transpl."},{"key":"35466_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.23876\/j.krcp.21.056","volume":"40","author":"IY Kim","year":"2021","unstructured":"Kim, I. Y., Lee, H. J. & Cheon, C. K. Fabry nephropathy before and after enzyme replacement therapy: important role of renal biopsy in patients with Fabry disease. Kidney Res. Clin. Pract. 40, 611\u2013619 (2021).","journal-title":"Kidney Res. Clin. Pract."},{"key":"35466_CR11","doi-asserted-by":"publisher","first-page":"e0152812","DOI":"10.1371\/journal.pone.0152812","volume":"11","author":"B Najafian","year":"2016","unstructured":"Najafian, B. et al. One year of enzyme replacement therapy reduces globotriaosylceramide inclusions in podocytes in male adult patients with Fabry disease. PLoS One. 11, e0152812 (2016).","journal-title":"PLoS One"},{"key":"35466_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2012030316","volume":"24","author":"C T\u00f8ndel","year":"2013","unstructured":"T\u00f8ndel, C. et al. Agalsidase benefits renal histology in young patients with Fabry disease. J. Am. Soc. Nephrol. 24, 137\u2013148 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"35466_CR13","doi-asserted-by":"crossref","unstructured":"Rusu, E. E. et al. The Impact of Kidney Biopsy for Fabry Nephropathy Evaluation on Patients\u2019 Management and Long-Term Outcomes: Experience of a Single Center. Biomedicines 10, (2022).","DOI":"10.3390\/biomedicines10071520"},{"key":"35466_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00428-008-0653-2","volume":"453","author":"C Valbuena","year":"2008","unstructured":"Valbuena, C. et al. Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch. 453, 329\u2013338 (2008).","journal-title":"Virchows Arch."},{"key":"35466_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/01913123.2021.2022054","volume":"46","author":"HYG Choung","year":"2022","unstructured":"Choung, H. Y. G., Jean-Gilles, J. & Goldman, B. Myeloid bodies is not an uncommon ultrastructural finding. Ultrastruct Pathol. 46, 130\u2013138 (2022).","journal-title":"Ultrastruct Pathol."},{"key":"35466_CR16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.5858\/arpa.2016-0418-RS","volume":"141","author":"P Colpart","year":"2017","unstructured":"Colpart, P. & F\u00e9lix, S. Fabry nephropathy. Arch. Pathol. Lab. Med. 141, 1127\u20131131 (2017).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"35466_CR17","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s40620-022-01375-0","volume":"35","author":"I Capuano","year":"2022","unstructured":"Capuano, I., Buonanno, P., Riccio, E., Crocetto, F. & Pisani, A. Parapelvic cysts: an imaging marker of kidney disease potentially leading to the diagnosis of treatable rare genetic disorders? A narrative review of the literature. J. Nephrol. 35, 2035\u20132046 (2022).","journal-title":"J. Nephrol."},{"key":"35466_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40620-023-01568-1","volume":"37","author":"V L\u2019Imperio","year":"2024","unstructured":"L\u2019Imperio, V. et al. Improvements in digital pathology equipment for renal biopsies: updating the standard model. J. Nephrol. 37, 221\u2013229 (2024).","journal-title":"J. Nephrol."},{"key":"35466_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40620-020-00805-1","volume":"34","author":"V L\u2019Imperio","year":"2021","unstructured":"L\u2019Imperio, V. et al. Digital pathology for the routine diagnosis of renal diseases: a standard model. J. Nephrol. 34, 681\u2013688 (2021).","journal-title":"J. Nephrol."},{"key":"35466_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40620-023-01775-w","volume":"37","author":"G Cazzaniga","year":"2024","unstructured":"Cazzaniga, G. et al. Time for a full digital approach in nephropathology: a systematic review of current artificial intelligence applications and future directions. J. Nephrol. 37, 65\u201376 (2024).","journal-title":"J. Nephrol."},{"key":"35466_CR21","doi-asserted-by":"publisher","first-page":"103111","DOI":"10.1016\/j.artmed.2025.103111","volume":"164","author":"Z Xiong","year":"2025","unstructured":"Xiong, Z. et al. Advances in kidney biopsy lesion assessment through dense instance segmentation. Artif. Intell. Med. 164, 103111 (2025).","journal-title":"Artif. Intell. Med."},{"key":"35466_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40620-021-01221-9","volume":"35","author":"CA Weis","year":"2022","unstructured":"Weis, C. A. et al. Assessment of glomerular morphological patterns by deep learning algorithms. J. Nephrol. 35, 417\u2013427 (2022).","journal-title":"J. Nephrol."},{"key":"35466_CR23","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41591-024-02857-3","volume":"30","author":"RJ Chen","year":"2024","unstructured":"Chen, R. J. et al. Towards a general-purpose foundation model for computational pathology. Nat. Med. 30, 850\u2013862 (2024).","journal-title":"Nat. Med."},{"key":"35466_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41698-024-00499-9","volume":"8","author":"JR Kaczmarzyk","year":"2024","unstructured":"Kaczmarzyk, J. R. et al. Open and reusable deep learning for pathology with WSInfer and QuPath. NPJ Precis Oncol. 8, 9 (2024).","journal-title":"NPJ Precis Oncol."},{"key":"35466_CR25","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1681\/ASN.2019020144","volume":"30","author":"M Hermsen","year":"2019","unstructured":"Hermsen, M. et al. Deep Learning-Based histopathologic assessment of kidney tissue. J. Am. Soc. Nephrol. 30, 1968\u20131979 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"35466_CR26","doi-asserted-by":"publisher","first-page":"e2534985","DOI":"10.1001\/jamanetworkopen.2025.34985","volume":"8","author":"P Ma","year":"2025","unstructured":"Ma, P. et al. AI-based system for analysis of electron microscope images in glomerular disease. JAMA Netw. Open. 8, e2534985 (2025).","journal-title":"JAMA Netw. Open."},{"key":"35466_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.kint.2023.09.011","volume":"105","author":"D Smerkous","year":"2024","unstructured":"Smerkous, D. et al. Development of an automated Estimation of foot process width using deep learning in kidney biopsies from patients with Fabry, minimal change, and diabetic kidney diseases. Kidney Int. 105, 165\u2013176 (2024).","journal-title":"Kidney Int."},{"key":"35466_CR28","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"35466_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41698-024-00652-4","volume":"8","author":"M Asadi-Aghbolaghi","year":"2024","unstructured":"Asadi-Aghbolaghi, M. et al. Learning generalizable AI models for multi-center histopathology image classification. NPJ Precis Oncol. 8, 151 (2024).","journal-title":"NPJ Precis Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35466-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35466-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35466-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:03:00Z","timestamp":1770332580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35466-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35466"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35466-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study, conducted as part of the project \u2018DIPLOMAT: DIgital PLatform for OMics and Artificial intelligence in Transplant and native rare renal diseases\u2019 (Grant no. PNRR-MR1-2022-12375735), complies with the principles of the Declaration of Helsinki and all relevant ethical regulations. All participant data were fully anonymized. Ethical approval was granted by the main coordinating center (Integrated University Hospital of Verona, protocol no. 16681, March 16, 2023), with integrated amendments approved by the Ethics Committee 2 of Catania (protocol no. 15\/CEL) and the Ethics Committee of Monza\/University of Milano-Bicocca (UNIMIB, file no. 4269).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical consideration"}}],"article-number":"5072"}}